Prospective Study
Copyright ©The Author(s) 2021.
World J Cardiol. Oct 26, 2021; 13(10): 574-584
Published online Oct 26, 2021. doi: 10.4330/wjc.v13.i10.574
Table 1 Baseline characteristics of the study population
Baseline characteristics
Control group (conventional hemostasis), n = 147
Oximetry – plethysmography group, n = 152
P value
Age (mean ± SD, yr) 61.5 ± 9.860.1 ± 11.60.2731
Male sex109 (74.1)115 (75.7)0.7642
Body mass index (mean ± SD, kg/m2)0.3432
Normal (18.5-24.9)31 ± 21.135 ± 23
Overweight (25-29.9)73 ± 49.763 ± 41.4
Obese (> 30)43 ± 29.354 ± 35.5
Risk factors/Comorbidities, n (%)
Hypertension89 (60.5)92 (60.5)0.9972
Diabetes mellitus29 (19.7)40 (26.3)0.1762
Insulin6 (20.7)14 (35.0)0.1963
Dyslipidemia112 (76.2)114 (75.0)0.8112
Smoking69 (46.9)74 (48.7)0.8502
History of coronary artery disease46 (31.3)52 (34.2)0.5912
Supraventricular arrhythmia39 (26.5)20 (13.2)0.0042
History of interventions, n (%)
Percutaneous coronary intervention 49 (33.3)56 (36.8)0.5252
Coronary artery bypass grafting11 (7.5)7 (4.6)0.2963